Q4 2015 Holdings
Filed 2016-02-16 | 47 holdings | $244.2K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2016-02-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $12.4K | 230,000 | 5.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $12.2K | 75,000 | 5.0% |
| Wright MED Group N V | ORD SHS 0.03 PAR | N96617118 | $12.1K | 500,000 | 5.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $11.8K | 230,000 | 4.8% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $11.7K | 200,000 | 4.8% |
| Seattle Genetics Inc | COM | 812578102 | $10.1K | 225,000 | 4.1% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $10.1K | 135,000 | 4.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $9.8K | 750,000 | 4.0% |
| Acadia Pharmaceuticals Inc(ACAD)A | COM | 004225108 | $8.9K | 250,000 | 3.6% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $8.9K | 250,000 | 0.1% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $8.1K | 120,000 | 3.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $7.9K | 250,000 | 3.2% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $7.8K | 275,000 | 3.2% |
| Bluebird BIO Inc | COM | 09609G100 | $7.7K | 120,000 | 3.2% |
| Biogen Inc(BIIB)A | COM | 09062X103 | $7.7K | 25,000 | 3.1% |
| Spectranetics Corp | COM | 84760C107 | $6.6K | 435,000 | 2.7% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $6.5K | 600,000 | 2.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $6.1K | 90,000 | 2.5% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $5.9K | 400,000 | 2.4% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $5.7K | 85,000 | 2.3% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.4K | 50,000 | 2.2% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $5.3K | 80,000 | 2.2% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $5.0K | 275,000 | 2.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $4.3K | 100,000 | 1.8% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $4.2K | 45,000 | 1.7% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $4.2K | 100,000 | 1.7% |
| Tandem Diabetes Care Inc | COM | 875372104 | $4.1K | 350,000 | 1.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.9K | 100,000 | 1.6% |
| Retrophin Inc | COM | 761299106 | $3.9K | 200,000 | 1.6% |
| Synergy Pharmaceuticals del | COM NEW | 871639308 | $3.4K | 600,000 | 1.4% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $3.2K | 410,000 | 1.3% |
| Alcobra LTD | SHS | M2239P109 | $3.1K | 500,000 | 1.3% |
| Tonix Pharmaceuticals Hldg C | COM NEW | 890260201 | $2.7K | 350,000 | 1.1% |
| Adaptimmune Therapeutics PLC(ADAPY)A | SPONDS ADR | 00653A107 | $2.5K | 210,000 | 1.0% |
| Entellus MED Inc | COM | 29363K105 | $2.5K | 150,000 | 1.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $2.5K | 350,000 | 1.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $2.3K | 151,630 | 0.9% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $2.3K | 30,000 | 0.9% |
| Clovis Oncology Inc(CLVSEUR)Call | COM | 189464100 | $1.8K | 50,000 | 0.7% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $1.6K | 150,000 | 0.7% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $1.3K | 55,000 | 0.5% |
| Corium Intl Inc | COM | 21887L107 | $1.0K | 125,000 | 0.4% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $996 | 60,000 | 0.4% |
| Amicus Therapeutics Inc(FOLD)Call | COM | 03152W109 | $970 | 100,000 | 0.4% |
| Catalyst Pharmaceuticals Inc(CPRX)A | COM | 14888U101 | $921 | 376,000 | 0.4% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $683 | 47,116 | 0.3% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $553 | 72,726 | 0.2% |
| Ocera Therapeutics Inc | COM | 67552A108 | $390 | 125,000 | 0.2% |